Anti-HLA-DRB1 [DJ9]
Invented at University Of Southern Denmark
- Datasheet
- References (2)
- Inventor Info
Info
Applications | FACS IHC IF WB |
Antigen/Gene or Protein Targets | Human major histocompatibility complex class II, DR (HLA-DRB1) |
Synonyms | Major histocompatibility complex, class II, DRB1 |
Reactivity | Human |
Relevance | HLA-DRB1 belongs to the HLA class II beta chain paralogs. The class II molecule is a heterodimer consisting of an alpha and a beta chain, both anchored in the membrane. HLA-DRB1 binds peptides derived from antigens that access the endocytic route of antigen presenting cells and presents them on the cell surface for recognition by the CD4 T-cells. Class II molecules are expressed in antigen presenting cells B lymphocytes, dendritic cells, macrophages. HLA-Drb1 is expressed at a level five times higher than its paralogs DRB3, DRB4 and DRB5. HLA-DRB1, clone DJ9, has been shown to be a relevant marker of bone marrow derived mesenchymal stem cells and their osteogenic derivatives (Andersen, D., et al., 2011). |
Host | Mouse |
Immunogen | Whole, intact hMSC-TERT Cells |
Subclass | IgG2a lambda |
Notes | Epitope: The epitope is on the extracellular side of the HLA-DRB1 molecule |
Research Area | Immunology |
References: 2 entries
Andersen et al. 2011. Mol Cells. 32(2):133-42. PMID: 21614487.
Development of novel monoclonal antibodies that define differentiation stages of human stromal (mesenchymal) stem cells.
Europe PMC ID: 21614487
Add a reference
References: 2 entries
Andersen et al. 2011. Mol Cells. 32(2):133-42. PMID: 21614487.
Development of novel monoclonal antibodies that define differentiation stages of human stromal (mesenchymal) stem cells.
Add a reference